For research use only. Not for therapeutic Use.
Penciclovir-d4 (CAS: 1020719-72-5), a premium pharmaceutical research compound designed for advanced antiviral studies. As a deuterated analog of Penciclovir, it offers enhanced stability and improved pharmacokinetic properties. Penciclovir-d4 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies for viral infections such as herpes simplex. Trusted by leading laboratories, Penciclovir-d4 is your go-to solution for cutting-edge antiviral research. Unlock new possibilities in viral treatment with Penciclovir-d4, where innovation meets reliability.
| Catalog Number | S000141 |
| CAS Number | 1020719-72-5 |
| Molecular Formula | C10H11D4N5O3 |
| Purity | ≥95% |
| IUPAC Name | 2-amino-9-[1,1,2,2-tetradeuterio-4-hydroxy-3-(hydroxymethyl)butyl]-1H-purin-6-one |
| InChI | InChI=1S/C10H15N5O3/c11-10-13-8-7(9(18)14-10)12-5-15(8)2-1-6(3-16)4-17/h5-6,16-17H,1-4H2,(H3,11,13,14,18)/i1D2,2D2 |
| InChIKey | JNTOCHDNEULJHD-LNLMKGTHSA-N |
| SMILES | [2H]C([2H])(C(CO)CO)C([2H])([2H])N1C=NC2=C1N=C(NC2=O)N |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Piret J, et al. Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management. Antimicrob Agents Chemother. 2011 Feb;55(2):459-72. [3]. Xiong Z, et al. Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living micewith mutant herpes simplex virus type 1 thymidine kinase PET reporter gene. J Nucl Med. 2006 Jan;47(1):130-9. |
